A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective
ConclusionsThis study predicts that the introduction of the MSA device would lead to favorable budget impact results for the treatment of medication-refractory mechanical GERD for commercial payers. Future analyses will benefit from inclusion of middle-ground treatments as well as longer time horizons.
Source: Surgical Endoscopy - Category: Surgery Source Type: research
More News: Acid Reflux | Endoscopy | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Insurance | Laparoscopy | Lower Endoscopy | Medicare | Study | Surgery | USA Health